Pigmentation Disorders Treatment Market to grow with a CAGR of 6.80%
Increasing
healthcare infrastructure and a supportive regulatory environment are the major
drivers for the Global Pigmentation Disorders Treatment Market.
According
to TechSci Research report, “Global Pigmentation Disorders Treatment Market Industry
Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, Global Pigmentation Disorders
Treatment Market has valued at USD 6.10 billion in 2022 and is anticipated to
witness an impressive growth in the forecast period with a CAGR of 6.80% through
2028. This can be due to collaborations and partnerships among leading
companies with a diverse approach to merge the expertise of individual
companies and to strengthen their position in the market.
Cosmetic concerns drive a significant demand
for pigmentation disorders treatment. Many individuals seek treatment for
pigmentation disorders primarily for aesthetic or cosmetic reasons. Pigmentation
disorders can lead to uneven skin tone, with areas of hyperpigmentation or
hypopigmentation that stand out against the surrounding skin. Many people seek
treatment to achieve a more uniform and even complexion, which is considered
cosmetically appealing. Clear, healthy-looking skin is often associated with
beauty and attractiveness. Individuals may pursue pigmentation disorder
treatments to enhance their overall appearance and boost their self-confidence.
Pigmentation disorders, particularly age spots and melasma, are often
associated with the aging process and sun damage. Treating these pigmentation
irregularities can help individuals achieve a more youthful and rejuvenated
appearance. In some cultures, and industries, appearance can play a significant
role in professional and social advancement. Clear and even skin may be seen as
an asset, motivating individuals to seek treatment.
Browse over XX market data Figures and spread through 110 Pages and an
in-depth TOC on "Pigmentation Disorders Treatment Market”
The market for different goods and therapies
used to treat pigmentation disorders, which are problems that alter the color
of the skin, hair, or eyes, is referred to as the pigmentation disorders
treatment market. Hypo- or hyper-pigmentation (loss of skin color) are two
possible symptoms of pigmentation disorders.
In
May 2023, A multi-year relationship between Sandoz, a pioneer in off-patent
medications, and Just - Evotec Biologics, an Evotec SE subsidiary with
headquarters in Seattle, was recently announced. The next step in establishing
Sandoz as a stand-alone off-patent medical firm, the deal includes the research
and production of several biosimilar medications with the potential for
expansion. Evotec Biologics has created
a highly effective, unique environment for cutting-edge, cost-effective
pharmaceutical discovery and production. The production of biologics may now be
done using an advanced continuous manufacturing method, a relatively recent but
well-established technology that offers improved quality and productivity.
Sandoz has the option to exploit this technology in accordance with the
conditions of the agreement.
Ethnic variations present a challenge in the
global pigmentation disorders treatment market. These variations relate to the
fact that individuals from different ethnic backgrounds may experience
pigmentation disorders differently and may respond differently to various treatment
modalities. People from various ethnic backgrounds have different skin types,
which can affect how pigmentation disorders manifest and respond to treatment.
For example, individuals with darker skin tones (Fitzpatrick skin types IV-VI)
are more prone to certain types of hyperpigmentation, such as melasma and
post-inflammatory hyperpigmentation, and may require specialized treatment
approaches. Certain pigmentation disorders may be more common or more severe in
specific ethnic groups. For instance, melasma is often more prevalent and
challenging to treat in individuals with skin color. The effectiveness of
pigmentation disorder treatments can vary among different ethnic groups. For
example, certain skin-lightening treatments may work better for individuals
with lighter skin, while others may be less effective or risk causing unwanted
side effects in individuals with darker skin tones.
Global Pigmentation Disorders Treatment Market segmentation
is based on
Indication, Treatment & Therapies,
End User, Region and Company
Based on Indication, Global Pigmentation Disorders Treatment
Market is segmented into Hyperpigmentation, Hypopigmentation. Hypopigmentation refers to a
skin condition characterized by the loss or reduction of pigmentation in the
skin, resulting in areas of lighter color compared to the surrounding skin.
This condition occurs when there is a decrease in the production of melanin,
the pigment responsible for skin, hair, and eye color. Hypopigmentation can
affect individuals of all skin tones and can be caused by various factors.
After skin inflammation or injury, such as burns, cuts, or certain skin
conditions, hypopigmented patches may develop. These areas lack melanin due to
damage to melanocytes during the healing process. Some individuals are born
with hypopigmented birthmarks, also known as congenital hypopigmentation. These
birthmarks appear as pale or light-colored areas of skin. Exposure to certain
chemicals, especially those used in skin-lightening products, can lead to
hypopigmentation. This is a common concern in regions where skin-lightening
practices are prevalent. Certain skin infections, such as leprosy, can result in
areas of hypopigmentation. Leprosy can damage nerves and lead to changes in
skin pigmentation.
Based on Region, North America dominated the Global Pigmentation Disorders
Treatment Market. North America has a strong culture of cosmetic and aesthetic
treatments. Patients often seek treatments to enhance their appearance and
address pigmentation issues, contributing to the demand for pigmentation
disorder treatments. North America is a diverse region with people of various
ethnic backgrounds. Pigmentation disorders can affect individuals of different
skin tones differently, leading to a diverse patient base seeking treatment. In many parts of North America, health
insurance coverage can include dermatological treatments, making it more
accessible for patients to seek treatment for pigmentation disorders. Consumer
awareness about pigmentation disorders and the availability of treatments is
relatively high in North America. Marketing efforts and educational campaigns
contribute to this awareness.
Asia-pacific region to fastest growth in
the Global Pigmentation Disorders Treatment Market. The Asia-Pacific region is
home to a significant portion of the world's population, including countries
like China and India with billions of people. With a large population, there is
a higher likelihood of individuals seeking pigmentation disorder treatment,
which drives market growth. Growing awareness about skincare and dermatological
treatments in the region has led to an increased demand for pigmentation disorder
treatments. As people become more conscious of their skin health, they are more
likely to seek professional treatment for pigmentation issues. Economic
development in many APAC countries has led to an increase in disposable income
levels. As people's income rises, they are more willing to invest in cosmetic
and dermatological treatments, including those for pigmentation disorders.
Rapid urbanization in the APAC region has brought about lifestyle changes that
can impact skin health. Factors like increased exposure to pollution and
changing dietary habits can contribute to skin issues, including pigmentation
disorders.
Some
of the major companies operating in the Global
Pigmentation Disorders Treatment Market include:
- Zerigo Health.
- Bausch Health Companies Inc.
- Glenmark Pharmaceuticals
Limited
- Novartis AG
- Pfizer Inc.
- Teva Pharmaceutical
Industries Ltd
- Bayer AG
- CLINUVEL
PHARMACEUTICALS LTD
- Strides Pharma
Science Limited
- Astellas Pharma
Inc.
Download Free Sample Report
Customers can also request
10% free customization on this report
“Certain areas, particularly in
North America, are projected to exert significant demand for pigmentation
treatment. The growth in the competitive landscape and the presence of
well-established companies in the market, committed to enhance the overall
wellbeing of people each year, are expected to contribute to a remarkable
growth of the Global Pigmentation Disorders Treatment Market in the forecast
period," said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based Global management consulting firm.
Pigmentation Disorders Treatment Market – Global Industry
Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Indication (Hyperpigmentation, Hypopigmentation), by Treatment & Therapies (Chemical Peels,
Dermabrasion, Laser Resurfacing, Melasma),
by End User (Dermatology Clinics, Hospitals), by region, and Competition evaluated
the future growth potential of Global Pigmentation Disorders Treatment Market and
provides statistics & information on market size, structure, and future
market growth. The report intends to provide innovative market intelligence and
help decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Pigmentation Disorders Treatment Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com